Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis

Genes to Cells

Volumn 20, Issue 6, 2015, Pages 464-480

  Goto, Maki ^a   Kitamura, Hiroshi ^a   Alam, Md Morshedul ^a   Ota, Nao ^a   Haseba, Takeshi ^b   Akimoto, Toshio ^b   Shimizu, Akio ^c   Takano Yamamoto, Teruko ^a   Yamamoto, Masayuki ^d   Motohashi, Hozumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c SOKA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 3; CHOLINE; GLUTATHIONE; METHIONINE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ADH5 PROTEIN, MOUSE; NFE2L2 PROTEIN, MOUSE;

ADH3 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; ENZYME ACTIVITY; GENE CONTROL; GENE DISRUPTION; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER PROTECTION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; VITAMIN DEFICIENCY; ANIMAL; C57BL MOUSE; DEFICIENCY; DIET; DISEASE COURSE; FATTY LIVER; GENETICS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

MUS;

ALCOHOL DEHYDROGENASE; ANIMALS; CHOLINE DEFICIENCY; DIET; DISEASE PROGRESSION; FATTY LIVER; GLUTATHIONE; LIPID METABOLISM; LIVER; METHIONINE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84930273955     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12237     Document Type: Article

References (47)

1. Anstee, Q.M. & Goldin, R.D. (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1-16.
2. Beigi, F., Gonzalez, D.R., Minhas, K.M., Sun, Q.A., Foster, M.W., Khan, S.A., Treuer, A.V., Dulce, R.A., Harrison, R.W., Saraiva, R.M., Premer, C., Schulman, I.H., Stamler, J.S. & Hare, J.M. (2012) Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc. Natl Acad. Sci. USA 109, 4314-4319.
3. Carter-Kent, C., Zein, N.N. & Feldstein, A.E. (2008) Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am. J. Gastroenterol. 103, 1036-1042.
4. Chowdhry, S., Nazmy, M.H., Meakin, P.J., Dinkova-Kostova, A.T., Walsh, S.V., Tsujita, T., Dillon, J.F., Ashford, M.L.J. & Hayes, J.D. (2010) Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic. Biol. Med. 48, 357-371.
5. Cox, A.G., Saunders, D.C., Kelsey, P.B. Jr, Conway, A.A., Tesmenitsky, Y., Marchini, J.F., Brown, K.K., Stamler, J.S., Colagiovanni, D.B., Rosenthal, G.J., Croce, K.J., North, T.E. & Goessling, W. (2014) S-nitrosothiol signaling regulates liver development and improves outcome following toxic liver injury. Cell Rep. 6, 56-69.
6. Deltour, L., Foglio, M.H. & Duester, G. (1999) Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid. J. Biol. Chem. 274, 16796-16801.
7. Foster, M.W., Yang, Z., Gooden, D.M., Thompson, J.W., Ball, C.H., Turner, M.E., Hou, Y., Pi, J., Moseley, M.A. & Que, L.G. (2012) Proteomic characterization of the cellular response to nitrosative stress mediated by s-nitrosoglutathione reductase inhibition. J. Proteome Res. 11, 2480-2491.
8. Goodloe, A.H., Evans, J.M., Middha, S., Prasad, A. & Olson, T.M. (2014) Characterizing genetic variation of adrenergic signalling pathways in Takotsubo (stress) cardiomyopathy exomes. Eur. J. Heart Fail. 16, 942-949.
9. Green, L.S., Chun, L.E., Patton, A.K., Sun, X., Rosenthal, G.J. & Richards, J.P. (2012) Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. Biochemistry 51, 2157-2168.
10. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. & Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
11. Kohlmeier, M., de Costa, K.A., Fischer, L.M. & Zeisel, S.H. (2005) Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc. Natl Acad. Sci. USA 102, 16025-16030.
12. Li, Z., Agellon, L.B., Allen, T.M., Umeda, M., Jewell, L., Mason, A. & Vance, D.E. (2006) The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3, 321-331.
13. Liu, L., Hausladen, A., Zeng, M., Que, L., Heitman, J. & Stamler, J.S. (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410, 490-494.
14. Liu, L., Yan, Y., Zeng, M., Zhang, J., Hanes, M.A., Ahearn, G., McMahon, T.J., Dickfeld, T., Marshall, H.E., Que, L.G. & Stamler, J.S. (2004) Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116, 617-628.
15. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N. & Rizzetto, M. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923.
16. Maruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., Motojima, K., Ishii, T., Nakane, A., Yamamoto, M. & Itoh, K. (2008) Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch. Biochem. Biophys. 477, 139-145.
17. Marzec, J.M., Christie, J.D., Reddy, S.P., Jedlicka, A.E., Vuong, H., Lanken, P.N., Aplenc, R., Yamamoto, T., Yamamoto, M., Cho, H.Y. & Kleeberger, S.R. (2007) Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 21, 2237-2246.
18. McMahon, M., Lamont, D.J., Beattie, K.A. & Hayes, J.D. (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl Acad. Sci. USA 107, 18838-18843.
19. Motohashi, H., Fujita, R., Takayama, M., Inoue, A., Katsuoka, F., Bresnick, E.H. & Yamamoto, M. (2011) Molecular determinants for small Maf protein control of platelet production. Mol. Cell. Biol. 31, 151-162.
20. Motohashi, H., Katsuoka, F., Engel, J.D. & Yamamoto, M. (2004) Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl Acad. Sci. USA 101, 6379-6384.
21. Motohashi, H., Katsuoka, F., Miyoshi, C., Uchimura, Y., Saitoh, H., Francastel, C., Engel, J.D. & Yamamoto, M. (2006) MafG sumoylation is required for active transcriptional repression. Mol. Cell. Biol. 26, 4652-4663.
22. Obeid, R. & Herrmann, W. (2009) Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett. 583, 1215-1225.
23. Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T.W. & Yamamoto, M. (2006) Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339, 79-88.
24. Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo-Perin, P. & Rizzetto, M. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35, 367-372.
25. Poortmans, J.R., Kumps, A., Duez, P., Fofonka, A., Carpentier, A. & Francaux, M. (2005) Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate. Med. Sci. Sports Exerc. 37, 1717-1720.
26. Que, L.G., Liu, L., Yan, Y., Whitehead, G.S., Gavett, S.H., Schwartz, D.A. & Stamler, J.S. (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308, 1618-1621.
27. Reddy, J.K. & Rao, M.S. (2006) Lipid metabolism and liver inflammation. II. Fatty liver diseases and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G852-G858.
28. Rosado, I.V., Langevin, F., Crossan, G.P., Takata, M. & Patel, K.J. (2011) Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat. Struct. Mol. Biol. 18, 1432-1434.
29. Sawa, T., Zaki, M.H., Okamoto, T., Akuta, T., Tokutomi, Y., Kim-Mitsuyama, S., Ihara, H., Kobayashi, A., Yamamoto, M., Fujii, S., Arimoto, H. & Akaike, T. (2007) Protein S-guanylation by the biological signal 8-nitroguanosine 3', 5'-cyclic monophosphate. Nat. Chem. Biol. 3, 727-735.
30. da Silva, R.P., Kelly, K.B., Rajabi, A.A. & Jacobs, R.L. (2014) Novel insights on interactions between folate and lipid metabolism. BioFactors 40, 277-283.
31. Sips, P.Y., Irie, T., Shinozaki, S., Sakai, M., Shimizu, N., Nguyen, R., Stamler, J.S., Chao, W., Kaneki, M. & Ichinose, F. (2013) Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression. Am. J. Physiol. Heart Circ. Physiol. 304, H1134-H1146.
32. Soga, T. & Heiger, D.N. (2000) Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. Anal. Chem. 72, 1236-1241.
33. Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., Ishii, T. & Yamamoto, M. (2010a) Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298, 283-294.
34. Sugimoto, M., Hirayama, A., Robert, M., Abe, S., Soga, T. & Tomita, M. (2010b) Prediction of metabolite identity from accurate mass, migration time prediction and isotopic pattern information in CE-TOFMS data. Electrophoresis 31, 2311-2318.
35. Sugimoto, M., Wong, D.T., Hirayama, A., Soga, T. & Tomita, M. (2010c) Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6, 78-95.
36. Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., Sakamoto, H., Motohashi, H. & Yamamoto, M. (2013) Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels. Mol. Cell. Biol. 33, 2402-2412.
37. Taguchi, K., Maher, J.M., Suzuki, T., Kawatani, Y., Motohashi, H. & Yamamoto, M. (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026.
38. Tang, C.H., Seeley, E.J., Huang, X., Wolters, P.J. & Liu, L. (2013a) Increased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice. Biochem. Biophys. Res. Commun. 442, 122-126.
39. Tang, C.H., Wei, W., Hanes, M.A. & Liu, L. (2013b) Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition. Cancer Res. 73, 2897-2904.
40. Uruno, A. & Motohashi, H. (2011) The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25, 153-160.
41. Vance, D.E. (2008) Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol. 19, 229-234.
42. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D.R., Harada, T., Engel, J.D. & Yamamoto, M. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35, 238-245.
43. Wei, W., Li, B., Hanes, M.A., Kakar, S., Chen, X. & Liu, L. (2010) S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci. Transl. Med. 2, 19ra13.
44. Wei, W., Yang, Z., Tang, C.H. & Liu, L. (2011) Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine. Carcinogenesis 32, 973-977.
45. Yao, Z. & Vance, S.E. (1988) The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 263, 2998-3004.
46. Yi, H.S., Lee, Y.S., Byun, J.S., Seo, W., Jeong, J.M., Park, O., Duester, G., Haseba, T., Kim, S.C., Park, K.G., Gao, B. & Jeong, W.I. (2014) Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice. Hepatology 60, 1044-1053.
47. Zhang, Y.-K.J., Yeager, R.L., Tanaka, Y. & Klaassen, C.D. (2010) Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. Toxicol. Appl. Pharmacol. 245, 326-334.